Hongwei Lü

2.3k total citations
106 papers, 1.7k citations indexed

About

Hongwei Lü is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Hongwei Lü has authored 106 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Molecular Biology, 22 papers in Cancer Research and 21 papers in Surgery. Recurrent topics in Hongwei Lü's work include Sphingolipid Metabolism and Signaling (10 papers), Cancer-related molecular mechanisms research (10 papers) and RNA modifications and cancer (9 papers). Hongwei Lü is often cited by papers focused on Sphingolipid Metabolism and Signaling (10 papers), Cancer-related molecular mechanisms research (10 papers) and RNA modifications and cancer (9 papers). Hongwei Lü collaborates with scholars based in China, United States and Australia. Hongwei Lü's co-authors include Hong Ji, Hong Xiang, Shuhua Chen, Le Lü, Yiming Li, Yafei Zhang, Xianling Zeng, Meng Fan, Lin Zeng and Jingjing Huang and has published in prestigious journals such as Advanced Materials, Journal of Biological Chemistry and Journal of Neuroscience.

In The Last Decade

Hongwei Lü

99 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hongwei Lü China 23 814 311 244 215 191 106 1.7k
Jianjun Zhu China 21 1.2k 1.5× 357 1.1× 251 1.0× 143 0.7× 210 1.1× 59 1.8k
Bao-Wei Wang Taiwan 25 845 1.0× 393 1.3× 122 0.5× 249 1.2× 150 0.8× 47 1.6k
Luigi Mele Italy 25 767 0.9× 383 1.2× 233 1.0× 192 0.9× 253 1.3× 62 1.6k
Zhaodong Li China 21 1.2k 1.4× 332 1.1× 270 1.1× 364 1.7× 322 1.7× 50 2.4k
Yan Ru Su United States 27 937 1.2× 236 0.8× 130 0.5× 249 1.2× 187 1.0× 65 1.8k
Anmin Chen China 26 1.1k 1.3× 432 1.4× 132 0.5× 366 1.7× 271 1.4× 131 2.3k
Lingling Liu China 22 645 0.8× 238 0.8× 128 0.5× 135 0.6× 267 1.4× 83 1.3k

Countries citing papers authored by Hongwei Lü

Since Specialization
Citations

This map shows the geographic impact of Hongwei Lü's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hongwei Lü with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hongwei Lü more than expected).

Fields of papers citing papers by Hongwei Lü

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hongwei Lü. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hongwei Lü. The network helps show where Hongwei Lü may publish in the future.

Co-authorship network of co-authors of Hongwei Lü

This figure shows the co-authorship network connecting the top 25 collaborators of Hongwei Lü. A scholar is included among the top collaborators of Hongwei Lü based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hongwei Lü. Hongwei Lü is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ouyang, Jie, Shuhua Chen, Hong Xiang, et al.. (2025). PACS2 initiates foam cell formation in macrophages through the ROS-PPARγ-CD36 positive feedback loop. Biochemical Pharmacology. 241. 117164–117164.
2.
Lü, Hongwei, Chunhong Jia, Annan Hu, et al.. (2025). Multifunctional copper-light synergistic prodrug nanosystems for specific reprogramming of tumour immunogenic endoplasmic reticulum stress. Biomaterials. 325. 123625–123625.
3.
Chen, Shuhua, Jie Ouyang, Huiqin Liu, et al.. (2024). Association of the triglyceride-glucose index with all-cause and cardiovascular mortality in patients with cardiometabolic syndrome: a national cohort study. Cardiovascular Diabetology. 23(1). 40 indexed citations
4.
Rong, Li, Shunle Li, Lin Shen, et al.. (2024). LINC00618 facilitates growth and metastasis of hepatocellular carcinoma via elevating cholesterol synthesis by promoting NSUN2-mediated SREBP2 m5C modification. Ecotoxicology and Environmental Safety. 285. 117064–117064. 10 indexed citations
5.
Wang, Xiaobo, Hongwei Lü, Qingyou Liu, et al.. (2024). An effective strategy for assembling the sex-limited chromosome. GigaScience. 13. 1 indexed citations
6.
7.
Zhao, Yuhang, Chan Zou, Liying Gong, et al.. (2024). Effect of Ticagrelor versus Clopidogrel on All-Cause and Cardiovascular Mortality in Acute Coronary Syndrome Patients with Hyperuricemia. Clinical Drug Investigation. 44(3). 163–174.
8.
Lü, Hongwei, Wenhao Yu, Lei Huang, et al.. (2024). Magnesium‐Impregnated Membrane Promotes Bone Regeneration in Rat Skull Defect by N‐Linked Glycosylation of SPARC via MagT1. Advanced Healthcare Materials. 14(2). e2402705–e2402705. 4 indexed citations
9.
Zhang, Yafei, Hongwei Lü, Hong Ji, & Yiming Li. (2023). Risk Factors for a High Comprehensive Complication Index after Splenectomy Plus Pericardial Devascularization for Portal Hypertension. The Turkish Journal of Gastroenterology. 34(10). 1041–1051. 1 indexed citations
10.
Jin, Longyu, et al.. (2023). Construction and validation of a novel prognostic model of neutrophil‑related genes signature of lung adenocarcinoma. Scientific Reports. 13(1). 18226–18226. 4 indexed citations
11.
Wang, Xiaowei, Hongwei Lü, Fang Luo, et al.. (2023). Lipid-like gemcitabine diester-loaded liposomes for improved chemotherapy of pancreatic cancer. Journal of Controlled Release. 365. 112–131. 10 indexed citations
12.
Chen, Shuhua, Hong Xiang, Shaoli Zhao, et al.. (2023). S1PR1 attenuates pulmonary fibrosis by inhibiting EndMT and improving endothelial barrier function. Pulmonary Pharmacology & Therapeutics. 81(1). 102228–102228. 6 indexed citations
13.
Li, Jialing, Hongwei Lü, Shuhua Chen, et al.. (2022). Trimethylamine oxide induces pyroptosis of vascular endothelial cells through ALDH2/ROS/NLRP3/GSDMD pathway.. PubMed. 47(9). 1171–1181. 7 indexed citations
14.
Chen, Ying, et al.. (2022). Research progress of endothelial‐mesenchymal transition in diabetic kidney disease. Journal of Cellular and Molecular Medicine. 26(12). 3313–3322. 45 indexed citations
15.
Liu, Yulan, Hong Xiang, Jie Ouyang, et al.. (2022). Glucolipotoxicity induces endothelial cell dysfunction by activating autophagy and inhibiting autophagic flow. Diabetes and Vascular Disease Research. 19(3). 1486945201–1486945201. 7 indexed citations
16.
Wang, Xuewen, Shuhua Chen, Hong Xiang, Ziwei Liang, & Hongwei Lü. (2021). Role of sphingosine‐1‐phosphate receptors in vascular injury of inflammatory bowel disease. Journal of Cellular and Molecular Medicine. 25(6). 2740–2749. 9 indexed citations
17.
Yang, Guoping, et al.. (2020). <p>Current Molecular Targeted Agents for Advanced Gastric Cancer</p>. OncoTargets and Therapy. Volume 13. 4075–4088. 16 indexed citations
18.
Ouyang, Jie, Zhihao Shu, Shuhua Chen, Hong Xiang, & Hongwei Lü. (2020). The role of sphingosine 1‐phosphate and its receptors in cardiovascular diseases. Journal of Cellular and Molecular Medicine. 24(18). 10290–10301. 25 indexed citations
19.
Zhang, Yafei, Xianling Zeng, Hongwei Lü, et al.. (2016). Association between cyclin D1 (CCND1) G870A polymorphism and gastric cancer risk: a meta-analysis. Oncotarget. 7(40). 66109–66118. 8 indexed citations
20.
Chen, Xi, Hong Ji, Tao Wu, et al.. (2014). miR-494 is an independent prognostic factor and promotes cell migration and invasion in colorectal cancer by directly targeting PTEN. International Journal of Oncology. 45(6). 2486–2494. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jianjun Zhu Breakdown of academic impact, for papers by Bao-Wei Wang Breakdown of academic impact, for papers by Luigi Mele Breakdown of academic impact, for papers by Zhaodong Li Breakdown of academic impact, for papers by Yan Ru Su Breakdown of academic impact, for papers by Anmin Chen Breakdown of academic impact, for papers by Lingling Liu
Rankless by CCL
2026